FIERCELY
FOCUSED
on the development of novel
treatments for patients with
B-cell malignancies and
autoimmune diseases.
Latest News
TG Therapeutics Recaps Schedule of Triple Therapy Data Presentations at the Upcoming 61st American Society of Hematology Annual Meeting and Exposition
Investor and analyst event to be held on Monday, December 9, 2019 at 7:30 PM ET at the Hyatt Regency Orlando featuring a fireside chat with leading clinical investigators NEW YORK , Dec. 06, 2019 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today recapped the schedule of triple therapy
Read More >
